Z-IETD-FMK,210344-98-2

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Z-IETD-FMK

CAS No. : 210344-98-2

MCE 国际站：Z-IETD-FMK

产品活性：Z-IETD-FMK (Z-IE(OMe)TD(OMe)-FMK) 是一种具有细胞渗透作用的选择性 caspase-8 抑制剂。Z-IETD-FMK 也是颗粒酶 B (granzyme B) 抑制剂。

研究领域：Apoptosis

作用靶点：Caspase

In Vitro: Z-IETD-FMK causes full inhibition only of the proapoptotic effect of TNFα with an IC₅₀ of 0.46 μM. Z-IETD-FMK and Z-VAD-FMK at non-toxic doses are found to be immunosuppressive and inhibit human T cell proliferation induced by mitogens and IL-2. They are shown to block NF-κB in activated primary T cells, but have little inhibitory effect on the secretion of IL-2 and IFN-γ during T cell activation. Z-IETD-FMK inhibits the cleavage of caspase-8 and only partially inhibits the cleavage of caspase-3 and PARP. Z-IETD-FMK can prevent the execution of apoptosis in retinal cells exposed to different apoptotic stimuli.

In Vivo: Pharmacological inhibition of caspase-8 by z-IETD-FMK robustly reduces tumour outgrowth and this is closely associated with a reduction in the release of pro-inflammatory cytokines, IL-6, TNF-α, IL-18, IL-1α, IL-33, but not IL-1β. Furthermore, inhibition of caspase-8 reduces the recruitment of innate suppressive cells, such as myeloid-derived suppressor cells, but not of regulatory T cells to lungs of tumour-bearing mice.

相关产品：Bioactive Compound Library Plus | Peptidomimetic Library | Peptide Library | Z-VAD-FMK | Z-DEVD-FMK | Q-VD-OPh | Belnacasan | Emricasan | Tauroursodeoxycholate | Ac-DEVD-CHO | Guggulsterone | Wedelolactone | Z-YVAD-FMK | Terfenadine | Ginsenoside Rh2 | Dehydrocorydaline | Ac-FLTD-CMK | OT-82 | Crustecdysone | BOC-D-FMK | Ac-YVAD-cmk | VRT-043198 | PAC-1 | Asperosaponin VI | Phenoxodiol | Taurodeoxycholic acid sodium hydrate | Fenbufen | ML132 | Paris saponin VII

热门产品线：重组蛋白 | 化合物库 | 天然产物 | 染料试剂 | PROTAC | 同位素标记物 | 寡核苷酸

Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds | Oligonucleotides

品牌介绍:
• MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供前沿最全的高品质小分子活性化合物；
• 10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
• 设有专业的实验中心和严格的质控、验证体系；
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
• 产品的生物活性多经各国客户实验验证；
• Nature, Cell, Science 等多种TOP期刊及制药专利收录了MCE客户的科研成果；
• 专业团队跟踪前沿的制药及生命科学研究进展，为您提供全球前沿的活性化合物；
• 与世界各大制药公司及知名科研机构建立了长期的合作。